Survival Study in Pediatric Patients with Medulloblastoma in a General Hospital in Tehran, Iran

[1] Huang, PI, et al. Large cell/anaplastic medulloblastoma is associated with poor prognosis—A retrospective analysis at a single institute. Childs Nerv Syst, 2017; 33(8):1285–1294. HuangPI Large cell/anaplastic medulloblastoma is associated with poor prognosis—A retrospective analysis at a single institute Childs Nerv Syst 2017 33 8 1285 1294 10.1007/s00381-017-3435-928488086 Search in Google Scholar

[2] Hadi, I, et al. Medulloblastoma in adults: A retrospective single institution analysis. Strahlenther Onkol, 2018; 194(3):225–234. HadiI Medulloblastoma in adults: A retrospective single institution analysis Strahlenther Onkol 2018 194 3 225 234 10.1007/s00066-017-1235-529147840 Search in Google Scholar

[3] Millard, NE, De Braganca, KC. Medulloblastoma. J Child Neurol, 2016; 31(12):1341–1353. MillardNE De BragancaKC Medulloblastoma J Child Neurol 2016 31 12 1341 1353 10.1177/0883073815600866499514626336203 Search in Google Scholar

[4] Kline, CN, et al. Case-based review: Pediatric medulloblastoma. Neurooncol Pract, 2017; 4(3):138–150. KlineCN Case-based review: Pediatric medulloblastoma Neurooncol Pract 2017 4 3 138 150 10.1093/nop/npx011590980529692919 Search in Google Scholar

[5] Nalita, N, et al. Survival and prognostic factors in pediatric patients with medulloblastoma in southern Thailand. J Pediatr Neurosci, 2018; 13(2):150–157. NalitaN Survival and prognostic factors in pediatric patients with medulloblastoma in southern Thailand J Pediatr Neurosci 2018 13 2 150 157 10.4103/JPN.JPN_111_17 Search in Google Scholar

[6] Prasad, KSV, et al. Clinicopathological study of pediatric posterior fossa tumors. J Pediatr Neurosci, 2017; 12(3):245–250. PrasadKSV Clinicopathological study of pediatric posterior fossa tumors J Pediatr Neurosci 2017 12 3 245 250 10.4103/jpn.JPN_113_16569666129204199 Search in Google Scholar

[7] Bavle, A., Parsons, DW. From one to many: Further refinement of medulloblastoma subtypes offers promise for personalized therapy. Cancer Cell, 2017; 31(6):727–729. BavleA. ParsonsDW From one to many: Further refinement of medulloblastoma subtypes offers promise for personalized therapy Cancer Cell 2017 31 6 727 729 10.1016/j.ccell.2017.05.01328609651 Search in Google Scholar

[8] Ryzhova, MV, et al. Characteristics of medulloblastoma in children under age of three years. Zh Vopr Neirokhir Im N N Burdenko, 2013; 77(1):3–10; discussion 11. RyzhovaMV Characteristics of medulloblastoma in children under age of three years Zh Vopr Neirokhir Im N N Burdenko 2013 77 1 3 10 discussion 11. Search in Google Scholar

[9] Gerber, NK, et al. Adult rhabdomyosarcoma survival improved with treatment on multimodality protocols. Int J Radiat Oncol Biol Phys, 2013; 86(1):58–63. GerberNK Adult rhabdomyosarcoma survival improved with treatment on multimodality protocols Int J Radiat Oncol Biol Phys 2013 86 1 58 63 10.1016/j.ijrobp.2012.12.016392796723414767 Search in Google Scholar

[10] Ramaswamy, V, et al. Risk stratification of childhood medulloblastoma in the molecular era: The current consensus. Acta Neuropathol, 2016; 131(6):821–831. RamaswamyV Risk stratification of childhood medulloblastoma in the molecular era: The current consensus Acta Neuropathol 2016 131 6 821 831 10.1007/s00401-016-1569-6486711927040285 Search in Google Scholar

[11] Northcott, PA, et al. Molecular subgroups of medulloblastoma. Expert Rev Neurother, 2012; 12(7):871–884. NorthcottPA Molecular subgroups of medulloblastoma Expert Rev Neurother 2012 12 7 871 884 10.1586/ern.12.66433444322853794 Search in Google Scholar

[12] von Stackelberg, A, et al. Toxicity, supportive care and costs of two chemotherapy protocols for treatment of childhood ALL in Russia: BFM 90m and MB 91. Eur J Cancer, 1999; 35(9):1349–1355. von StackelbergA Toxicity, supportive care and costs of two chemotherapy protocols for treatment of childhood ALL in Russia: BFM 90m and MB 91 Eur J Cancer 1999 35 9 1349 1355 10.1016/S0959-8049(99)00112-410658526 Search in Google Scholar

[13] Menon, G, Krishnakumar, K, Nair, S. Adult medulloblastoma: Clinical profile and treatment results of 18 patients. J Clin Neurosci, 2008; 15(2):122–126. MenonG KrishnakumarK NairS Adult medulloblastoma: Clinical profile and treatment results of 18 patients J Clin Neurosci 2008 15 2 122 126 10.1016/j.jocn.2007.06.00718078755 Search in Google Scholar

[14] De, B, et al. Long-term outcomes of adult medulloblastoma patients treated with radiotherapy. J Neurooncol, 2018; 136(1):95–104. DeB Long-term outcomes of adult medulloblastoma patients treated with radiotherapy J Neurooncol 2018 136 1 95 104 10.1007/s11060-017-2627-1591827929019042 Search in Google Scholar

[15] Wefers, AK, et al. Subgroup-specific localization of human medulloblastoma based on pre-operative MRI. Acta Neuropathol, 2014; 127(6):931–933. WefersAK Subgroup-specific localization of human medulloblastoma based on pre-operative MRI Acta Neuropathol 2014 127 6 931 933 10.1007/s00401-014-1271-524699697 Search in Google Scholar

[16] Friedrich, C, et al. Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: A prospective observational multicentre study. Eur J Cancer, 2013; 49(4):893–903. FriedrichC Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: A prospective observational multicentre study Eur J Cancer 2013 49 4 893 903 10.1016/j.ejca.2012.10.00623182688 Search in Google Scholar

[17] Kunschner, LJ, et al. Survival and recurrence factors in adult medulloblastoma: The M.D. Anderson Cancer Center experience from 1978 to 1998. Neuro Oncol, 2001; 3(3):167–173. KunschnerLJ Survival and recurrence factors in adult medulloblastoma: The M.D. Anderson Cancer Center experience from 1978 to 1998 Neuro Oncol 2001 3 3 167 173 10.1093/neuonc/3.3.167192061711465397 Search in Google Scholar

[18] Massimino, M, et al. Histological variants of medulloblastoma are the most powerful clinical prognostic indicators. Pediatr Blood Cancer, 2013; 60(2):210–216. MassiminoM Histological variants of medulloblastoma are the most powerful clinical prognostic indicators Pediatr Blood Cancer 2013 60 2 210 216 10.1002/pbc.2422522693015 Search in Google Scholar

[19] Chan, AW, et al. Adult medulloblastoma: Prognostic factors and patterns of relapse. Neurosurgery, 2000; 47(3):623–631, discussion 631–632. ChanAW Adult medulloblastoma: Prognostic factors and patterns of relapse Neurosurgery 2000 47 3 623 631 discussion 631–632. 10.1227/00006123-200009000-00018 Search in Google Scholar

[20] Smoll, NR. Relative survival of childhood and adult medulloblastomas and primitive neuroectodermal tumors (PNETs). Cancer, 2012; 118(5):1313–1322. SmollNR Relative survival of childhood and adult medulloblastomas and primitive neuroectodermal tumors (PNETs) Cancer 2012 118 5 1313 1322 10.1002/cncr.2638721837678 Search in Google Scholar

[21] Call, JA, et al. Long-term outcomes and role of chemotherapy in adults with newly diagnosed medulloblastoma. Am J Clin Oncol, 2014; 37(1):1–7. CallJA Long-term outcomes and role of chemotherapy in adults with newly diagnosed medulloblastoma Am J Clin Oncol 2014 37 1 1 7 10.1097/COC.0b013e31826b9cf0436193423111362 Search in Google Scholar